How long did you take this medication to work?
sponsored
Phensuximide contraindications
sponsored
Phensuximide is contraindicated in:
1) patients with porphyria
2) patients who are hypersensitive to phenobarbital.
References
- DTP/NCI. "phensuccimide: The NCI Development Therapeutics Program (DTP) provides services and resources to the academic and private-sector research communities worldwide to facilitate the discovery and development of new cancer therapeutic agents.". https://dtp.cancer.gov/dtpstandard/s... (accessed September 17, 2018).
- European Chemicals Agency - ECHA. "phensuximide: The European Chemicals Agency (ECHA) is an agency of the European Union which is the driving force among regulatory authorities in implementing the EU's groundbreaking chemicals legislation for the benefit of human health and the environment as well as for innovation and competitiveness.". https://echa.europa.eu/ (accessed September 17, 2018).
- NIST. "Phensuximide". http://www.nist.gov/srd/nist1a.cfm (accessed September 17, 2018).
Reviews
The results of a survey conducted on ndrugs.com for Phensuximide are given in detail below. The results of the survey conducted are based on the impressions and views of the website users and consumers taking Phensuximide. We implore you to kindly base your medical condition or therapeutic choices on the result or test conducted by a physician or licensed medical practitioners.User reports
Consumer reported side effects
No survey data has been collected yetConsumer reviews
There are no reviews yet. Be the first to write one! |
Information checked by Dr. Sachin Kumar, MD Pharmacology